Literature DB >> 8963384

Detection of Helicobacter pylori DNA in gastric juice by the polymerase chain reaction: comparison with findings in bacterial culture and the detection of tissue IgA and serum IgG antibodies against Helicobacter pylori.

N Matsukura1, M Onda, A Tokunaga, S Kato, K Yamashita, M Ohbayashi.   

Abstract

The detection of Helicobacter pylori in gastric juice by the polymerase chain reaction (PCR) was undertaken in 124 patients with peptic ulcer or chronic gastritis. PCR products were evaluated by agarose gel electrophoresis and Southern hybridization of H. pylori-specific DNA sequences. Positive and negative results of the PCR analysis in 72 examinations were compared with those from bacterial culture, and with the detection of tissue IgA antibody against H. pylori by enzyme-linked immunosorbent assay ELISA; Serion, Wuerzburg, Germany, and detection of serum IgG antibody against H. pylori by ELISA; Radim Pomezia, Italy. Thirty-four PCR-positive samples evaluated by electrophoresis and hybridization coincided with positive samples in 56% of bacterial cultures, 59% of tissue IgA antibody identifications, and 94% of serum IgG antibody evaluations; 26 PCR-negative samples coincided with negative samples in 96% of bacterial cultures, 81% of tissue IgA antibody evaluations, and 38% of serum IgG assessments. We compared the detection achieved with the H. pylori PCR assay in gastric juice with that in biopsies taken from the antrum and upper corpus in 90 examinations, and found them to be both positive in 34 (38%) and 36 (40%) of specimens, both negative in 37 (41%) and 30 (33%) specimens, gastric juice-positive but biopsy-negative in 10 (11%) and 12 (13%) specimens, and vice versa in 9 (10%) and 12 (13%) specimens, when detected by electrophoresis and hybridization, respectively, showing equivalent detection rates. In relation to the type of disease, the positive PCR assay results with gastric juice, evaluated by electrophoresis and hybridization, respectively, were: gastric ulcer 34/53 (64%) and 39/53 (74%), duodenal ulcer 23/38 (61%) and 25/38 (66%), and chronic gastritis 20/33 (61%) and 23/33 (70%), showing no significant difference in positive rates between peptic ulcer and chronic gastritis. Of the samples of 16 patients with H. pylori-positive gastric juice by the PCR assay, 7 were negative by PCR assay analyzed by electrophoresis and hybridization after the completion of treatment H. pylori. However, after treatment, 3 were negative on electrophoresis but still had positive results with hybridization, indicating that a minimal number of bacilli may have still remained. Detection of H. pylori in gastric juice has potential advantages for examining H. pylori infection in the entire stomach and for follow up after treatment for the eradication of H. pylori.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8963384     DOI: 10.1007/bf02349633

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  17 in total

1.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

2.  Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy.

Authors:  W Langenberg; E A Rauws; J H Oudbier; G N Tytgat
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

3.  Evidence for the occurrence of the same strain of Campylobacter pylori in the stomach and dental plaque.

Authors:  B Shames; S Krajden; M Fuksa; C Babida; J L Penner
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

4.  An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group.

Authors: 
Journal:  Lancet       Date:  1993-05-29       Impact factor: 79.321

5.  Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.

Authors:  M Asaka; T Kimura; M Kudo; H Takeda; S Mitani; T Miyazaki; K Miki; D Y Graham
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

6.  Detection of Helicobacter pylori by using the polymerase chain reaction.

Authors:  J L Valentine; R R Arthur; H L Mobley; J D Dick
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

7.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.

Authors:  E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

8.  Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection.

Authors:  A S Peña; H P Endtz; G J Offerhaus; A Hoogenboom-Verdegaal; W van Duijn; N de Vargas; G den Hartog; J Kreuning; J van der Reyden; R P Mouton
Journal:  Digestion       Date:  1989       Impact factor: 3.216

9.  Detection of serum IgG antibody against Helicobacter pylori from childhood in a Japanese population.

Authors:  N Matsukura; M Onda; A Tokunaga; T Teramoto; I Fujita; T Okuda; K Yamashita
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

10.  Helicobacter pylori may be transmitted through gastrofiberscope even after manual Hyamine washing.

Authors:  M Katoh; D Saito; T Noda; S Yoshida; Y Oguro; Y Yazaki; T Sugimura; M Terada
Journal:  Jpn J Cancer Res       Date:  1993-02
View more
  8 in total

Review 1.  Diagnosis of Helicobacter pylori: what should be the gold standard?

Authors:  Saurabh Kumar Patel; Chandra Bhan Pratap; Ashok Kumar Jain; Anil Kumar Gulati; Gopal Nath
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy.

Authors:  Hólmfridur Helgadóttir; Sigrún H Lund; Sveinbjörn Gizurarson; David C Metz; Einar S Björnsson
Journal:  J Clin Gastroenterol       Date:  2020-03       Impact factor: 3.062

3.  Relationship between gastric disease and deletion of cag pathogenicity island genes of Helicobacter pylori in gastric juice.

Authors:  Osamu Kawamura; Masami Murakami; Osamu Araki; Takuro Yamada; Sayaka Tomizawa; Yasuyuki Shimoyama; Keiko Minashi; Masaki Maeda; Motoyasu Kusano; Masatomo Mori
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

Review 4.  Helicobacter pylori detection and antimicrobial susceptibility testing.

Authors:  Francis Mégraud; Philippe Lehours
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

5.  Cytotoxin genes of Helicobacter pylori in chronic gastritis, gastroduodenal ulcer and gastric cancer: an age and gender matched case-control study.

Authors:  N Matsukura; M Onda; S Kato; H Hasegawa; K Okawa; T Shirakawa; A Tokunaga; K Yamashita; A Hayashi
Journal:  Jpn J Cancer Res       Date:  1997-06

Review 6.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

7.  A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice.

Authors:  Chao-Hung Kuo; Chung-Jung Liu; Ching-Chia Yang; Fu-Chen Kuo; Huang-Ming Hu; Hsiang-Yao Shih; Meng-Chieh Wu; Yen-Hsu Chen; Hui-Min David Wang; Jian-Lin Ren; Deng-Chyang Wu; Lin-Li Chang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract.

Authors:  Norio Matsukura; Shigeki Yokomuro; Sirikan Yamada; Takashi Tajiri; Trichak Sundo; Tohru Hadama; Shigeru Kamiya; Zenya Naito; James G Fox
Journal:  Jpn J Cancer Res       Date:  2002-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.